From time to time the CHS collaborates with market research companies. We believe that market studies can provide valuable information to companies on how to improve their products and services.

The CHS is helping with the publicizing of this market research opportunity to chapters, but is not providing any information about members.

Keep your eyes open for postings about future market research studies.



December 2020


Novo Nordisk Canada is inviting individuals living with moderate to severe hemophilia A or B to participate in a virtual meeting.

The Hemophilia Journey virtual meeting will be held on Tuesday, January 19, 2021 from 7:00 to 9:00 p.m. EST.

The objectives of this meeting are to:

  • Gain insights into the everyday experiences of individuals living with hemophilia;
  • Better understand their unmet needs in managing their hemophilia and the burden of hemophilia on patients;
  • Examine the programs and strategies that are currently making a difference in their lives and understand what additional tools and resources could further make an impact.

Spaces are limited. Attendees who are selected to participate in the meeting will be contacted separately to confirm their attendance. Attendees will be compensated for their time.

To indicate your interest in participating in the Hemophilia Journey virtual meeting, please register by January 5, 2021 using the following link:

If you have any questions, you are invited to contact Tara Robson, the event organizer at ANTIBODY Healthcare Communications via phone at 416-319-0225 or by e-mail: